No photo of Loredana Amoroso

View Scopus Profile

Loredana Amoroso

  • 211 Citations
  • 8 h-Index
20042018
If you made any changes in Pure these will be visible here soon.

Fingerprint Dive into the research topics where Loredana Amoroso is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 13 Similar Profiles
Neuroblastoma Medicine & Life Sciences
Pediatrics Medicine & Life Sciences
Bone Marrow Medicine & Life Sciences
Topotecan Medicine & Life Sciences
Neoplasms Medicine & Life Sciences
temozolomide Medicine & Life Sciences
HLA-G Antigens Medicine & Life Sciences
Brachiocephalic Veins Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 2004 2018

  • 211 Citations
  • 8 h-Index
  • 34 Article
  • 1 Review article

Phase I results of a phase I/II study of weekly nab-paclitaxel in paediatric patients with recurrent/refractory solid tumours: A collaboration with innovative therapies for children with cancer

Moreno, L., Casanova, M., Chisholm, J. C., Berlanga, P., Chastagner, P. B., Baruchel, S., Amoroso, L., Gallego Melcón, S., Gerber, N. U., Bisogno, G., Fagioli, F., Geoerger, B., Glade Bender, J. L., Aerts, I., Bergeron, C., Hingorani, P., Elias, I., Simcock, M., Ferrara, S., Le Bruchec, Y. & 3 others, Slepetis, R., Chen, N. & Vassal, G., Sep 2018, In : European Journal of Cancer. 100, p. 27-34 8 p.

Research output: Contribution to journal › Article

Investigational Therapies
Pediatrics
Ewing's Sarcoma
Neoplasms
Neutropenia

Phase I results of a phase I/II study of weekly nab-paclitaxel in paediatric patients with recurrent/refractory solid tumours: A collaboration with innovative therapies for children with cancer

Moreno, L., Casanova, M., Chisholm, J. C., Berlanga, P., Chastagner, P. B., Baruchel, S., Amoroso, L., Melcón, S. G., Gerber, N. U., Bisogno, G., Fagioli, F., Geoerger, B., Glade Bender, J. L., Aerts, I., Bergeron, C., Hingorani, P., Elias, I., Simcock, M., Ferrara, S., Le Bruchec, Y. & 3 others, Slepetis, R., Chen, N. & Vassal, G., 2018, In : European journal of cancer. 100, p. 27-34 8 p.

Research output: Contribution to journal › Article

6 Citations (Scopus)

Topotecan-vincristine-doxorubicin in stage 4 high-risk neuroblastoma patients failing to achieve a complete metastatic response to rapid COJEC: A SIOPEN study

Amoroso, L., Erminio, G., Makin, G., Pearson, A. D. J., Brock, P., Valteau-Couanet, D., Castel, V., Pasquet, M., Laureys, G., Thomas, C., Luksch, R., Ladenstein, R., Haupt, R., Garaventa, A. & On behalf of SIOPEN Group, Jan 1 2018, In : Cancer Research and Treatment. 50, 1, p. 148-155 8 p.

Research output: Contribution to journal › Article

Topotecan
Vincristine
Neuroblastoma
Doxorubicin
Pediatrics

Topotecan-Vincristine-Doxorubicin in Stage 4 High-Risk Neuroblastoma Patients Failing to Achieve a Complete Metastatic Response to Rapid COJEC: A SIOPEN Study

SIOPEN Group, Jan 2018, In : Cancer Research and Treatment. 50, 1, p. 148-155 8 p.

Research output: Contribution to journal › Article

Topotecan
Vincristine
Neuroblastoma
Doxorubicin
Pediatrics
1 Citation (Scopus)

Updated clinical and biological information from the two-stage phase II study of imatinib mesylate in subjects with relapsed/refractory neuroblastoma

Morandi, F., Amoroso, L., Dondero, A., Castriconi, R., Parodi, S., Luksch, R., Casale, F., Castellano, A., Garaventa, A., Moretta, A., Bottino, C., Ponzoni, M. & Corrias, M. V., Sep 2 2018, In : OncoImmunology. 7, 9, e1468953.

Research output: Contribution to journal › Article

Neuroblastoma
RNA Isoforms
Biomarkers
Bone Marrow
Therapeutics